Abstract
Scattergrams between vancomycin and telavancin demonstrated susceptibility agreement rates of 99.96, 99.65, and 100.00% for Staphylococcus aureus, Enterococcus faecalis, and streptococci, respectively. A single very major error was obtained against E. faecalis, while vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant and teicoplanin-susceptible (VanB phenotype) E. faecalis were responsible for major and minor errors. These results support the use of vancomycin to infer telavancin susceptibility among indicated pathogens, except VISA, which should be tested for telavancin susceptibility.
Cite
CITATION STYLE
Mendes, R. E., Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2015). Analysis of vancomycin susceptibility testing results for presumptive categorization of telavancin. Journal of Clinical Microbiology, 53(8), 2727–2730. https://doi.org/10.1128/JCM.00611-15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.